Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 184
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Numinus to Host Q3 2022 Results Conference Call on July 14,...
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate...
FILAMENT HEALTH ANNOUNCES SIXTH PATENT ISSUANCE
Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel...
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research...
PT334 – Prof. David Nutt – The Human Brain, Addiction, and...
PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch
Psychedelic Bulletin #109 – California Decrim. Back on the Agenda; Reanalysis...
PT333 – Miriam Volat, MS & T. Cody Swift, MFT –...
FILAMENT HEALTH ANNOUNCES PRIVATE PLACEMENT OF UNITS AND CONVERTIBLE DEBENTURE UNITS...
Load more